Vactosertib is under clinical development by MedPacto and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase I drugs for Non-Hodgkin Lymphoma have a 71% phase transition ...
AstraZeneca Plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech activities, including its digital transformation strategies, ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 11.06% ...
Accenture Plc (ACN) stock saw a modest uptick, ending the day at $361.63 which represents a slight increase of $2.86 or 0.80% from the prior close of $358.77. The stock opened at $359.95 and touched a ...